Navigation Links
Prolong Pharmaceuticals Presents Novel Multi-Pronged Approach To Treating Sickle Cell Disease At The SCDAA Meeting
Date:9/26/2013

SOUTH PLAINFIELD, N.J., Sept. 26, 2013 /PRNewswire/ -- Prolong Pharmaceuticals LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemia resulting from oxygen deficiency and hemolysis, presented a novel approach to treating the comorbidities of sickle cell disease (SCD) at the 41st Sickle Cell Disease Association of America convention "Moving Forward: Advocating for New Discoveries, Advancements and Breakthroughs."  The SCDAA meeting is currently underway in Linthicum, Maryland.  

(Logo: http://photos.prnewswire.com/prnh/20130926/NY87531LOGO )

Sickle Cell Disease (SCD) is a blood disorder caused by a defective hemoglobin molecule resulting in the production of abnormally shaped and fragile red blood cells.  These sickle cells break down very readily in a process called hemolysis, and also cause ischemia (restricted blood flow).  These two interrelated events lead to damaging inflammation, production of toxic waste products and further deprive cells and tissues of a critical oxygen supply.  Although SCD is a clearly defined genetic disease, patients suffer from a host of comorbidities resulting from these events.  Unless both of these disease pathways are interrupted, cell death, tissue damage and organ dysfunction can result.

At the scientific session, Abraham Abuchowski, Ph.D., Chief Scientific Officer and CEO, stated, "It has become evident that no single approach will be sufficient to treat the comorbidities of SCD such as pain, stroke, dactylitis and leg wounds. The best hope to reducing these complications will be a product that acts early on in the disease and at multiple target sites.  SANGUINATE™ holds the promise of reducing or preventing the comorbidities of SCD."

Prolong's product, SANGUINATE, has been desi
'/>"/>

SOURCE Prolong Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
2. Prolong TM, a New Revolutionary First Line Treatment for Premature Ejaculation is Licensed in Europe
3. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
6. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
7. Icahn Issues Statement Regarding Amylin Pharmaceuticals
8. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
11. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Human Insulin Market Development ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778) Explore more ...
(Date:7/28/2015)... LINCOLNSHIRE, Ill. , July 28, 2015 ... acumen on par with their levels of clinical excellence. ... (AACC) Annual Meeting & Clinical Lab Expo, Sysmex is ... deliver a comprehensive and intuitive ecosystem that will help ... four key areas, Sysmex aims to add even more ...
(Date:7/28/2015)... July 28, 2015 Rigel Pharmaceuticals, Inc. (Nasdaq: ... report its second quarter 2015 financial results after market ... management will follow the announcement with a live ... (1:30pm Pacific Time) to discuss the financial results. ... call by dialing 855-892-1489 (domestic) or 720-634-2939 (international) ...
Breaking Medicine Technology:Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results 2
(Date:7/28/2015)... ... July 28, 2015 , ... ... has authorized the Company, from time to time and depending on market conditions, ... up to $25 million. Repurchases will be made in open market or privately ...
(Date:7/28/2015)... ... July 28, 2015 , ... Fertility specialist Dr. Lisa Hasty of ... by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been ... and peers in the metro area as one of the most respected doctors in ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... of Acute Coronary Syndromes (ACS-Heart Attack, Sudden Death, or Angina), many of whom ... cardiology is the identification of individuals with active yet undetected sub-clinical disease, who ...
(Date:7/28/2015)... ... July 28, 2015 , ... PeopleKeys ... the regional winner of the EY Entrepreneur of the Year award. The award ... of home healthcare, and the innovative work they have done in incorporating new ...
(Date:7/28/2015)... ... 2015 , ... Please join us for the 5th Annual Step for Hope 5K Run/Walk ... Avenue and Lies Road in Carol Stream. All are welcome. , Now in its ... and help to support individuals and families affected by a brain aneurysm. , “We ...
Breaking Medicine News(10 mins):Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 2Health News:Receiving Recognition for Compassionate Care and Innovative Processes: Celtic Healthcare CEO Arnie Burchianti Wins Regional EY Entrepreneur of the Year Award 3Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2
... likely to struggle in adulthood, study finds, , WEDNESDAY, July ... chronic daily headaches in their early teens, a new study ... before their early 20s. , For the remaining 12 percent, ... published in the July 15 online issue of Neurology ...
... ... will be introducing its latest advancement in high throughput immunoassay testing with the AIA-2000 Automated ... developer of accurate and reliable analyzers for immunoassay testing. , ... South San Francisco, CA (PRWEB) July 15, 2009 -- At ...
... PRINCETON, N.J., July 15 Diabetes patients taking ... insulin in their pump for up to six days following ... labeling change, diabetes care company Novo Nordisk announced today.(1) The ... pump reservoir for two days. This makes NovoLog((R)) the first ...
... , RENO, Nev., July 15 The Fraternal Order of Eagles ... week as part of the 2009 FOE International Convention ... donate over $100 million each year including more than $5 million to Diabetes ... from cities all over the U.S. and Canada work hard to raise money ...
... Recent Death of Infant in Madrid ... SPRING, Md., July 15 The American Society for Parenteral and Enteral Nutrition ... practice of nutrition support therapy, is saddened by the recent death of an ... an IV catheter and not through a feeding tube in his stomach. ...
... of dilated cardiomyopathy , WEDNESDAY, July 15 (HealthDay News) ... chronic heart failure in some children and adults with ... cardiomyopathy -- the most common cause of heart failure ... a heart transplant -- is a condition in which ...
Cached Medicine News:Health News:Many Kids Outgrow Chronic Headaches 2Health News:Many Kids Outgrow Chronic Headaches 3Health News:Immunoassay at AACC 2009: Tosoh Launches AIA-2000 Automated Immunoassay Analyzer 2Health News:FDA Approves NovoLog(R) Labeling Update 2Health News:FDA Approves NovoLog(R) Labeling Update 3Health News:FDA Approves NovoLog(R) Labeling Update 4Health News:Fraternal Order of Eagles Award $630,000 in Grants at International Convention 2Health News:Tube Feeding Error: Fatal Medical Mistakes 2Health News:Tube Feeding Error: Fatal Medical Mistakes 3Health News:Gene Mutation Is Linked to Heart Muscle Disease 2
The ultimate ultrasound system for clinical ophthalmologists....
The Ultrasonic BioMicroscope (UBM P40) provides the highest ultrasound resolution for imaging....
EchoScan US-3300 takes accurate axial length and corneal thickness measurements in either automatic or manual modes. It is available in a single configuration or in combination with the A scan for ma...
... eye. Whether used as part of ... independently to accommodate a specific scanning ... to accommodate maximizing the image resolution. ... tonometer-mounted, hand-held and immersion techniques. Unique ...
Medicine Products: